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Abstract
Background: Treatment of headache disorders is not always optimal. Patients are treated in multiple
ways, and the lack of scientific arguments for referral and the insufficient implementation of guidelines
result in unclear treatment strategies.
The coexistence of headache and neck pain can lead to the referral to a musculoskeletal physiotherapist.
This treatment can only be successful if an underlying cervical segmental dysfunction is present. In such
cases a physical treatment can be a valuable option that should be considered.
The aim of this study is to identify prognostic therapeutic patient characteristics and to increase the
number of correct physiotherapy referrals.
Methods/design:  This trial is designed to identify patient characteristics which can influence the
prognosis of the patient. Patients with recurrent headache and co-existent neck pain are recruited via a
multicenter setup. After screening for eligibility, subjects are tested at baseline and randomly allocated to
one of two treatment groups. Testing includes the administering of questionnaires (a Headache Diagnosis
Questionnaire, Headache Inventory List and the Headache Impact Test (HIT-6)) and physical tests
(Thermal Stimuli, Manual Cervical Spine Examination and Pressure Algometry). Treatment groups are a
usual care group (UC) administered by the General Practitioner (GP) and a usual care plus musculoskeletal
physiotherapy treatment group (UCMT). UC is based on the Dutch GP Guideline for Headache. UCMT
consists of the UC plus a combination of exercises and spinal cervical mobilisations. Follow-up
measurements consist of the completion of the Headache Inventory List, the HIT-6 and scoring of the
global perceived effect (GPE). The latter allowing the distinction between responders (positive effect) and
non-responders (no effect or worse). Logistic regression analysis will be used to identify the specific
patient characteristics of the responders and the non-responders. The additional value of the
musculoskeletal physiotherapy will be examined. Follow-up measurements up to 52 weeks are scheduled.
Discussion: This trial aims to identify prognostic patient characteristics, in order to supply a useful
diagnostic tool for all health care workers, dealing with headache sufferers.
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Background
Headache is a common disorder with a high impact, both
on the socio-economic level and on the level of the indi-
vidual sufferer [1-3]. Not all headache patients seek head-
ache treatment, although severe pain and disability have
been reported even in large proportions of non-care seek-
ers [4]. Patients do not look for treatment partially out of
ignorance of effective treatments or because of previous
negative experiences [2,5].
Guidelines for headache management in primary care are
available [6,7]. These guidelines provide diagnostic and
therapeutic algorithms and stepped treatment plans for
the most common headache types. Apparently they are
insufficiently applied in daily practice as patients are fre-
quently referred to neurology clinics after no more than
one visit to the general practitioners (GP) office [8].
Physical treatments of the cervical spine, provided by
musculoskeletal physiotherapists can be considered as a
treatment option in headache sufferers. The effects of
musculoskeletal physiotherapy for various headache
types are reported both in RCT's and systematic reviews
[9-16]. The combination of mobilisations and low-load
exercises focussing on the cranio-cervical flexion is of par-
ticular interest nowadays [9,13]. The conclusions of sys-
tematic reviews are not firm due to methodological
limitations of the selected studies, but there are indica-
tions that musculoskeletal physiotherapy directed to the
cervical spine can be beneficial for some headache
patients [11,15]. Reductions in headache frequency,
intensity and duration of headache attacks have been
reported [9,13]. Dowson et al. recommend physical ther-
apy (muscle relaxing and mobilising exercises) for those
patients who report neck stiffness [17,18]. The neck-head-
ache relationship is however not always causal: neck pain
experienced by migraine patients for example can be a
result of sensitization [19]. The co-existence of headache
and neck pain and/or the presence of neck stiffness might
therefore not be a sufficient indication to prescribe physi-
cal treatment of the cervical spine.
These therapeutic uncertainties contribute to patients'
treatment dissatisfaction. Relatively high percentages of
headache sufferers are not satisfied with the headache care
they receive. Harpole and co-workers investigated the
headache burden and patient satisfaction with existing
management in primary care, using patient-administered
surveys. Of the 385 responders, who all contacted a GP
because of their headache, 48 % reported problems with
headache management and 17 % were dissatisfied with
the headache care. Patients with a high headache-related
impairment reported more problems with their headache
management [20]. Walling et al. found that 26 % were
dissatisfied in their sample of 447 migraine patients [21].
The prevalence and burden of headache, the dissatisfac-
tion percentages and the diversity in headache treatments,
call for a refinement of headache management.
The identification prior to the start of a treatment, of
patients whom might react properly to the treatment, is
necessary to reduce the risk of a negative outcome. For this
purpose, patient characteristics which predict the treat-
ment outcome (prognostic characteristics) need to be
determined.
Prognostic factors are multifactorial. Jull and Stanton ana-
lysed the results of 152 CErvicogenic Headache (CEH)
patients who participated in one of the three active treat-
ment groups in a headache trial [9]. The prognostic value
of socio-demographic factors, headache features, physical
impairments of the cervical spine, neck pain and disability
and patients' perceptions of influences on their headaches
(locus of control) was investigated. They were unable to
identify a systematic pattern of prognostic factors. Only
the presence of light-headedness appeared to be a clini-
cally relevant predictor of a bad outcome. Of the physical
tests only joint pain on palpation had a prognostic value
[22]. Of their tests only this palpation could be used for
prognostic uses.
Our study has a double aim. Our primary aim is to analyse
the prognostic value of a series of physical tests. Our sec-
ondary aim is to compare two currently applied treatment
strategies, being the usual care (UC) administered by a
medical doctor following a stepped guideline [7], and the
UC plus a musculoskeletal physiotherapy treatment pro-
tocol (UCMT), described by Jull et al [9].
Our research questions are: first, can we identify prognos-
tic patient characteristics, and second, what is the addi-
tional value of a musculoskeletal physiotherapy approach
in the treatment of headache disorders?
Methods/design
Study design
A randomised clinical trial with blinded assessment and
unblinded treatment and with a follow-up period of 12
months was developed. The research protocol was
approved by the Medical Ethics Committees of the Uni-
versity Hospital of the Vrije Universiteit Brussel (UZ Brus-
sel) and of the University Hospital of Antwerp (UZA).
Patients selection
Using a multicenter setup, patients will be recruited at GPs
offices, from outpatient clinics of the neurology depart-
ment of the academic hospitals UZ Brussel and UZA and
via advertisements.BMC Musculoskeletal Disorders 2007, 8:38 http://www.biomedcentral.com/1471-2474/8/38
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All participating medical doctors (GP's and neurologists)
were contacted and personally informed about the study
protocol. Additional information is provided on an
informative website [23].
The advertisements contain a weblink to an informative
recruitment website [24]. On this site detailed informa-
tion is provided, followed by an online eligibility screen-
ings procedure.
Different recruitment strategies can result in a heteroge-
nous study population. This will not necessarily affect
treatment outcome [25]. Subgroups will be compared at
baseline. In case differences are found these will be taken
into account in the statistical analysis (see section 'Analy-
ses').
In- and exclusion criteria
Dutch speaking patients with a combination of recurrent
headache and neck pain since minimum two months and
at least twice a month with an active help-request (who
consider to undergo treatment) are recruited. They have to
be at least 18 years old and be willing to participate. Sub-
jects are excluded in case of cluster headache or trigeminal
neuralgia. To avoid false positive tests with the quantita-
tive sensory tests (see description of measurements),
patients with peripheral neuropathies and co-morbidity
of chronic musculoskeletal pain will be excluded. Because
of the neck mobility tests, people with rheumatoid arthri-
tis, Down syndrome and/or a history of neck surgery will
be excluded. The presence of red flags for headache (warn-
ing signs for serious causes of the headache) is an extra
exclusion criterion. Pregnant women are also excluded, as
pregnancy influences the frequency and intensity of head-
aches with migraine properties.
To avoid biased patients (with treatment preferences), we
excluded patients who received physiotherapy treatment
for their headaches during the last 12 months or patients
whose prescribed medication was changed during the last
two months.
The included headache types are migraine, tension-type
headache and CEH. For migraine and tension-type head-
ache the IHS criteria are used [26], for CEH the criteria of
the Cervicogenic Headache International Study Group
(CHISG) [27].
For the patients recruited via internet sites and advertise-
ments, an additional exclusion criteria is set: a HIT-6 score
of at least 56 points. From this level, the HIT-6 scoring
advises the patient to contact his/her GP in order to start
a treatment [28].
All subjects sign a written informed consent.
Baseline measurements
Baseline measurements consist of two parts: the comple-
tion of questionnaires and physical tests. All baseline
measurements are performed by a blinded examiner/
rater, as subjects are allocated at random after the baseline
measurements (see below: Randomization).
A. Questionnaires
All questionnaires can be completed online using PHP-
surveyor [29]. In case a participant does not have the
opportunity to fill in the questionnaires online, a paper
version including an addressed and stamped envelope is
provided. The rater is blinded: the online version is com-
pleted by the participants themselves, the paper versions
are inserted in the computer software by an independent,
blinded rater.
■ Headache Diagnosis Questionnaire
This questionnaire was developed to screen for CEH [30].
It consists of 56 questions in total: 34 concerning head-
ache, 15 concerning neck pain and 7 concerning shoulder
pain. It registers headache-associated features in a system-
atic way. Additionally it creates an inventory of pain
intensity (Visual Analogue Scale, VAS) of headache, neck
pain and shoulder pain (average pain intensity over the
last three months and at the moment of fulfilment of the
questionnaire), frequency and duration of the headache
history. It was developed as a CEH questionnaire and
additional questions screening for migraine and tension-
type headache characteristics were added. The question-
naire will be validated throughout the trial [30,31].
■ The Headache Impact Test (HIT-6) [32]
The HIT-6 is a short questionnaire, consisting of 6 items:
pain intensity, social functioning, role functioning, vital-
ity, cognitive functioning and psychological distress. It
has a recall period of four weeks. Scores vary between 36
and 78. Higher scores correspond with a higher headache
burden.
The six items are derived from a total pool of 89 items, 54
items from the computer based HIT pool and 35 items
that were proposed by headache experts [32]. Its psycho-
metric properties have been investigated extensively
[32,33]. Reliability analyses (internal consistency, alter-
nate forms, test-retest) are good to excellent (scores rang-
ing from 0.78 to 0.90). Construct validity has been
investigated using the SF-8 as criterion, and negative cor-
relations were found. The HIT-6 is able to differentiate
between mild, moderate and severe headache forms. Pain,
role functioning and psychological distress are the most
differentiating items. A difference of three points is
believed to be clinically important (responsiveness).
These results were generated in a general population [32],BMC Musculoskeletal Disorders 2007, 8:38 http://www.biomedcentral.com/1471-2474/8/38
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and were recently confirmed in a population of recent
headache sufferers recruited in a headache centre [33].
■ Headache Inventory List
This questionnaire is used to register the frequency and
intensity of the headache, medication use (both over-the-
counter and prescription), headache-related professional
care and absenteeism. A similar patient administered
questionnaire has been used by Peters et al. [34].
Pain intensity is registered on a VAS for pain at the
moment of completion of the questionnaire and for the
average pain of the last 4 weeks. Medication intake is
monitored, precautionary and treatment medication,
both on prescription or over-the-counter.
Headache-related professional care is monitored provid-
ing a list of health-care workers who might be contacted
by a headache patient (e.g. pharmacist, nurse, and psy-
chologist). Patients have to mark those health-care work-
ers they contacted as well as the frequency of the visits.
This registration will allow the analysis of additional ther-
apies that might interfere with the treatment protocol of
the study.
Sick leave is scored by the number of absence days.
For all questionnaires a recall period of four weeks is cho-
sen, in correspondence with the recall period of the HIT-
6. At baseline and at the last administration of the ques-
tionnaires (follow-up at 52 weeks) the absenteeism of the
past 12 months is monitored.
B. Physical tests
Physical examination of the cervical spine
The cervical spine is examined using a manual rotation
test and a pain provocation test.
The rotation test is performed for both rotations (left and
right) at the C0-2 and C2-7 regions. It is scored for mobil-
ity (hyper/hypo or normal), endfeel (too hard, normal,
too soft or empty) and for the onset of pain (yes/no). The
test is considered positive if two out of three criteria were
positive, i.e. hyper- or hypo-mobility, too hard or soft or
empty endfeel, and the provocation of pain.
The pain provocation test is the adapted Spurling test
(passive lateral flexion, homolateral rotation, extension
and axial compression at the end). It is performed on all
segments starting at C0-1 and descending till C6-7. It is
scored for pain provocation and endfeel. When pain is
provoked during this test, a VAS (0 mm – 100 mm) is
recorded. If subjects rate their pain > 20 mm on a VAS, this
test is considered positive.
These tests can discriminate between asymptomatic con-
trols and patients with neck pain [35]. In this study we
apply them to identify an underlying painful segmental
dysfunction.
Thermal and pressure stimuli
Thermal and pressure stimuli are used to detect sensitisa-
tion. Stimuli are applied in cranial and extra-cranial
regions. To screen for central sensitization, measurements
were also taken on the dorsal side of the index, on the tibi-
alis anterior (pressure) and on the thenar (temperature).
Thermal stimuli will be investigated using the TSA II Ther-
motest (Medoc Advanced Medical Systems Ltd. 1
Ha'Dekel Street P.O. Box 423, Ramat Yishai 30095 Israel).
A thermode of 30 × 30 mm is attached first to the skin of
the hand (palmar thenar, C6), next to the mastoid process
(C2) and finally to the temple (trigeminal nerve). Starting
from a baseline temperature of 32°C, the intensity of the
stimulus will vary following the method of limits protocol
(+/- 1°C/s). Four modalities are tested: cold and warm
sensation (CS and WS) and cold and heat pain detection
thresholds (CP and HP). First subjects are asked to press a
button as soon a change in temperature is perceived (CS
and WS, 4 stimuli). Second they have to push the button
when the temperature stimulus is perceived as unpleas-
ant/painful (CP and HP, 3 stimuli). All measurements are
performed bilaterally. The average of the repetitions is
used for further calculations.
The sequence of the thermal stimuli is chosen to familiar-
ise the subjects with the test: it is reassuring to have the
first set of stimuli on the hand and not on the head, which
is the site of the complaints. This method has been shown
to be reliable [36].
Pressure stimuli are measured using a hand held algom-
eter (Somedic AB, Farsta, Sweden). Pain detection thresh-
olds will be measured on the temple, the mastoid process,
the dorsal side of the index and on the tibialis anterior
muscle. The average of three measurements will be used
for further calculations. Subjects have to report when the
feeling of pressure alone changes into a feeling of pressure
and pain.
Quantitative Sensory Tests are psychophysical tests. To
increase the reliability and ecological validity of the tests,
all measurements will be performed at the participants'
home.
Follow-up measurements
After approximately 7, 12, 26 and 52 weeks, participants
will be asked to complete the Headache Inventory List and
HIT-6 again. For all questionnaires a recall period of fourBMC Musculoskeletal Disorders 2007, 8:38 http://www.biomedcentral.com/1471-2474/8/38
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weeks is chosen, in correspondence with the recall period
of the HIT-6.
The global perceived effect (GPE) is measured using a 7
point scale, ranging from 'completely recovered' to 'worse
than ever'. This way of measuring GPE has been used in
similar studies in which the effect of commonly applied
therapeutic approaches have been compared [37,38].
Responders (positive effect) and non-responders (no
effect or worse) can be identified.
The follow-up measurements are also available online
ensuring a blinded rater assessment. The questionnaires
which are returned in paper version (from participants
without internet connection) will be inserted in the soft-
ware by an independent blinded rater.
Primary and secondary outcome measures
Two primary outcome measures will be used in this study:
GPE and the HIT-6 score.
Reduction in headache frequency, headache pain inten-
sity, medication intake, absenteeism and looking for pro-
fessional help will be used as secondary outcome
measures.
Interventions
The UCMT group will receive a musculoskeletal physio-
therapy treatment during 6 weeks following the protocol
described by Jull et al. [10,11]. It consists of a combina-
tion of spinal mobilisations and exercise therapy. Spinal
mobilisations consist of low and/or high-velocity cervical
joint mobilization techniques. Each therapist can decide
the technique of choice based on his own clinical skills
and the patient's situation. Therapeutic exercises consist
of low-load endurance exercises, more precisely cranio
cervical flexion exercises. A maximum of 12 sessions
(twice a week over a period of 6 weeks) is provided. Each
session lasts approximately 30 minutes.
All participants receive a letter containing recommenda-
tions for treatment, based on the available evidence. This
letter is to be handed over to the therapist. After the six
weeks treatment period, the therapists will be contacted
by phone to check for treatment integrity.
As a guideline for the UC treatment, the protocol from the
Dutch College of GPs is used. It consists of a stepped
approach to diagnose and treat primary headache disor-
ders. In the Flemish part of Belgium this is the guideline
with the lowest access threshold. The GP receives an email
containing a weblink to the Dutch College of GPs guide-
line [7]. In this treatment group treatment integrity will be
analysed via the Headache Inventory List, which is to be
completed in the follow-up measurements.
Randomisation
After baseline measurements patients are randomised.
Subjects are randomised using blinded envelopes, using a
pre-stratification for the headache diagnosis. So, an enve-
lope for migraine, tension-type headache and CEH is pro-
vided. Each envelope contains 10 notes, five mentioning
usual care and five mentioning usual care plus manual
therapy. This to ensure that for each 10 patients with the
same diagnosis, the same number of patients is ran-
domised in one of the two treatment groups. Due to the
randomisation after testing all tests are performed by a
blinded rater.
Statistical analyses, power and sample size calculation
The prognostic capacity of the initial series of tests (phys-
ical examination of the cervical spine and QST) will be
calculated by means of a logistic regression analysis, com-
paring the results of the responders with those of the non-
responders. Instead of starting with a full regression
model, two known prognostic factors, derived from the
study from Jull and Stanton [8] will be included in the
analysis a priori. Those two factors are 'light-headedness'
and 'joint pain on palpation'. Consequently a backwards
stepwise selection will be used, including the two known
factors in the smaller models. Differences at baseline
between the two treatment groups will be included in the
regression models as potential prognostic factors. The
plausibility of the signs will be considered to check the
logical contribution of each factor in the model. The
power of the obtained models will be analysed via the
area under the ROC-curve.
Group differences and effect sizes can be calculated for
headache intensity and frequency, medication intake,
HIT-6 scores and absenteeism. The number of responders
and non-responders in both groups will be compared.
GPE is a dichotomous variable. Sample size calculations
with a significance level of p < 0.05, an event rate of 0.50
in the usual care group and of 0.70 in the usual care plus
musculoskeletal physiotherapy group a power of 80% and
an equal amount of subjects in both treatment groups
result in a sample size of 93 subjects in each treatment
group. This results in a total of 186 subjects.
The results of all subjects will be analysed, regardless of
their treatment adherence (intention-to-treat analysis).
Discussion
This study aims to improve the care for headache patients.
Therefore we compare two commonly applied therapeutic
strategies: the usual care, administered by the GP, and
usual care plus musculoskeletal physiotherapy treatment.
We primarily want to screen for prognostic patient charac-
teristics.BMC Musculoskeletal Disorders 2007, 8:38 http://www.biomedcentral.com/1471-2474/8/38
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For the selection of patients we start from the clinical pres-
entation of symptoms: we look for patients with a combi-
nation of headache and neck pain. We not only focus on
CEH, but allow migraine and tension-type headache
patients to be included as well. We believe this is justified
because of the common combination of symptoms.
Is it ethical to provide musculoskeletal physiotherapy
treatment to patients with migraine symptoms? Several
systematic reviews have been performed concerning the
value of physical treatments directed to the cervical spine
in headache disorders such as migraine [10,11,39]. These
reviews were unable to draw firm conclusions due to the
methodological quality of the included RCTs. However,
there are indications that physical treatments can be ben-
eficial. There is no group that receives only musculoskele-
tal physiotherapy treatment. The combination with the
GP care is allowed at all times. Prohibiting the use of med-
ication, certainly during a headache attack, would be
unethical.
We use a diagnostic headache questionnaire. The value of
diagnostic questionnaires in comparison with a clinical
interview has been studied [40]. Questionnaires have
their limitations [40]. They lack the flexibility of a clinical
interview, in which questions can be repeated or reformu-
lated whenever a patient does not fully understand their
meaning. Then again the phrasing of a questionnaire is
more standardised which we consider as preferential. Ras-
mussen et al. also mention methodological pitfalls. They
particularly mention the internal consistency and test-
retest repeatability. Reliability scores of our questionnaire
are very high (kappa: 0.982, sign.: <0.001), as well as the
internal consistency (Cronbach alpha: 0.87) [30]. Consid-
ering these methodological aspects we believe that the use
of this questionnaire is justified.
We preferred not to include generic questionnaires like
the SF-36 in our outcome measures. This was mostly out
of practical considerations: the initial set of question-
naires is quite long to complete. Adding another question-
naire can discourage patients to participate. The influence
of migraine, tension-type headache and CEH on Quality
Of Life (QOL) has been investigated before [41].
Quantitative Sensory Testing using thermal and pressure
stimuli have been used to study patho-physiological
mechanisms in headache patients [42-46]. General hyper-
sensitivity has been demonstrated to be present in Whip-
lash patients with moderate to severe symptoms and not
in recovered patients or those with mild symptoms [47].
This indicates the potential value of this test in predicting
the evolution of a disorder.
The number of participants is the weak point of every clin-
ical study. A pilot running from February 06 to June 06,
with only first line recruitments resulted in 15 referred
patients. To obtain the required number of patients the
way of recruitment was adapted. Second line and adver-
tisement recruitments were also included. The results will
be analysed as in any multicenter trial: intercenter differ-
ences will be analysed to verify if patients can be pooled.
No training sessions dealing with the study protocol or
treatments were organised for the participating medical
doctors or therapists. This is a potential weakness of the
study protocol. It was impossible to organize these ses-
sions. The referring doctors receive no financial incentives
or compensations whatsoever for participation in this
study. They participate out of goodwill. Additional time
investments would decrease this goodwill. We tried to
have their commitment by informing them personally
and by providing additional information on a website
developed for that purpose [23].
The therapists could not be trained in advance either as it
is not known in advance which therapists will participate.
This depends on the patient's residence. Therefore the let-
ter with treatment recommendations is provided.
The treatment part of the study protocol is a potential bar-
rier for doctors to participate in the study. Clinicians have
treatment preferences. Study protocols require a step back
from daily routine, and maybe ask to prescribe a treat-
ment one does not fully support. This can influence the
selection of patients: one can refer only those patients
who do not fit in the regular schema or where the regular
schema was not successful. To anticipate this phenome-
non, we contacted all doctors personally, informed them
about the study protocol and asked them to collaborate.
We labelled one of the treatment groups as the usual care
group to link the study protocol with every day practice
explicitly.
Patients who are willing to participate are informed prior
to the study (written informed consent). Patients with a
preference for one of the treatment groups are potentially
biased when included.
For these reasons Pfeiffer et al. decided to use a prospec-
tive cohort study rather than a randomised controlled trial
[48]. In case a study protocol acquires a too low number
of patients, using a non-randomised protocol can be an
option.
With this study we hope to detect variables that can pre-
dict the outcome of the treatment of headache patients,
and that consequently can help to improve the care for
these patients.BMC Musculoskeletal Disorders 2007, 8:38 http://www.biomedcentral.com/1471-2474/8/38
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